logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 15
  • 1
    Glass, Steve
    Group Ceo born in June 1967
    Individual (5 offsprings)
    Officer
    2024-02-15 ~ 2025-10-17
    OF - Director → CIF 0
  • 2
    Swarbrick, Andrew Thomas
    Non - Executive Chairman born in October 1953
    Individual (21 offsprings)
    Officer
    2017-04-01 ~ 2023-03-11
    OF - Director → CIF 0
  • 3
    Hill, Christian Anthony Harry
    Director born in June 1975
    Individual (12 offsprings)
    Officer
    2013-08-27 ~ 2025-04-01
    OF - Director → CIF 0
    Mr Christian Anthony Harry Hill
    Born in June 1975
    Individual (12 offsprings)
    Person with significant control
    2016-04-06 ~ 2018-09-18
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 4
    Beard, Stephen Michael
    Chief Consulting Officer born in July 1965
    Individual (5 offsprings)
    Officer
    2021-07-29 ~ 2022-06-30
    OF - Director → CIF 0
  • 5
    Murphy, Sebastian
    Chief Financial Officer born in February 1984
    Individual (13 offsprings)
    Officer
    2023-10-17 ~ 2025-07-30
    OF - Director → CIF 0
    Murphy, Sebastian
    Individual (13 offsprings)
    Officer
    2023-02-06 ~ 2023-02-06
    OF - Secretary → CIF 0
    2023-10-17 ~ 2025-07-30
    OF - Secretary → CIF 0
  • 6
    Lambertson, Marianne
    Born in June 1970
    Individual (3 offsprings)
    Officer
    2025-10-16 ~ 2026-02-23
    OF - Director → CIF 0
  • 7
    Harries, Mark
    Director born in February 1966
    Individual (6 offsprings)
    Officer
    2014-12-15 ~ 2021-05-01
    OF - Director → CIF 0
  • 8
    Bruce, Nicholas James
    Market Access Director born in November 1967
    Individual (5 offsprings)
    Officer
    2019-07-23 ~ 2020-10-29
    OF - Director → CIF 0
  • 9
    Rooney, Patrick Arthur
    Individual (14 offsprings)
    Officer
    2015-06-17 ~ 2017-05-31
    OF - Secretary → CIF 0
  • 10
    Keith, Ian
    Director born in February 1973
    Individual (12 offsprings)
    Officer
    2020-07-21 ~ 2023-09-08
    OF - Director → CIF 0
  • 11
    Hill, Dawn May
    Director born in May 1967
    Individual (7 offsprings)
    Officer
    2012-09-11 ~ 2023-03-11
    OF - Director → CIF 0
    Hill, Dawn May
    Individual (7 offsprings)
    Officer
    2020-10-29 ~ 2023-03-11
    OF - Secretary → CIF 0
    Mrs Dawn May Hill
    Born in May 1967
    Individual (7 offsprings)
    Person with significant control
    2016-04-06 ~ 2018-09-18
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 12
    Collins, Timothy John
    Born in March 1970
    Individual (29 offsprings)
    Officer
    2025-11-25 ~ now
    OF - Director → CIF 0
  • 13
    Spacie, Daniel John
    Chief Executive Officer born in August 1971
    Individual (28 offsprings)
    Officer
    2022-05-16 ~ 2023-12-21
    OF - Director → CIF 0
  • 14
    Rooney, Ruth Caroline
    Individual (103 offsprings)
    Officer
    2012-10-31 ~ 2015-06-17
    OF - Secretary → CIF 0
  • 15
    MAP LIFE SCIENCES LIMITED
    11002642
    Upper Pendrill Court, Ermine Street North, Papworth Everard, Cambridge, England
    Active Corporate (17 parents, 4 offsprings)
    Person with significant control
    2018-09-18 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

MAP PATIENT ACCESS LIMITED

Period: 2022-01-25 ~ now
Company number: 08209281
Registered names
MAP PATIENT ACCESS LIMITED - now
MAP PHARMA LTD - 2012-11-30
Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Average Number of Employees
402023-11-01 ~ 2024-12-31
342022-11-01 ~ 2023-10-31
Intangible Assets
100,000 GBP2024-12-31
Property, Plant & Equipment
29,739 GBP2024-12-31
39,092 GBP2023-10-31
Fixed Assets
129,739 GBP2024-12-31
39,092 GBP2023-10-31
Debtors
Current
4,552,741 GBP2024-12-31
1,753,132 GBP2023-10-31
Cash at bank and in hand
130,322 GBP2024-12-31
196,225 GBP2023-10-31
Current Assets
4,683,063 GBP2024-12-31
1,949,357 GBP2023-10-31
Creditors
Current, Amounts falling due within one year
-3,224,485 GBP2024-12-31
Net Current Assets/Liabilities
1,458,578 GBP2024-12-31
920,783 GBP2023-10-31
Total Assets Less Current Liabilities
1,588,317 GBP2024-12-31
959,875 GBP2023-10-31
Net Assets/Liabilities
1,580,770 GBP2024-12-31
953,474 GBP2023-10-31
Equity
Called up share capital
1,001 GBP2024-12-31
1,001 GBP2023-10-31
Retained earnings (accumulated losses)
1,579,769 GBP2024-12-31
952,473 GBP2023-10-31
Equity
1,580,770 GBP2024-12-31
953,474 GBP2023-10-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
202023-11-01 ~ 2024-12-31
Computers
332023-11-01 ~ 2024-12-31
Intangible Assets - Gross Cost
Development expenditure
100,000 GBP2024-12-31
Intangible Assets
Development expenditure
100,000 GBP2024-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
5,190 GBP2024-12-31
5,190 GBP2023-10-31
Computers
115,245 GBP2024-12-31
111,457 GBP2023-10-31
Property, Plant & Equipment - Gross Cost
130,249 GBP2024-12-31
126,461 GBP2023-10-31
Property, Plant & Equipment - Other Disposals
Computers
-10,924 GBP2023-11-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals
-10,924 GBP2023-11-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
4,558 GBP2023-10-31
Computers
72,997 GBP2023-10-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
87,369 GBP2023-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
284 GBP2023-11-01 ~ 2024-12-31
Owned/Freehold
23,989 GBP2023-11-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Computers
-10,848 GBP2023-11-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-10,848 GBP2023-11-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
4,842 GBP2024-12-31
Computers
85,854 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
100,510 GBP2024-12-31
Property, Plant & Equipment
Plant and equipment
348 GBP2024-12-31
632 GBP2023-10-31
Computers
29,391 GBP2024-12-31
38,460 GBP2023-10-31
Trade Debtors/Trade Receivables
Current
654,990 GBP2024-12-31
662,105 GBP2023-10-31
Amounts Owed by Group Undertakings
Current
3,594,489 GBP2024-12-31
809,452 GBP2023-10-31
Other Debtors
Current
10,252 GBP2023-10-31
Prepayments/Accrued Income
Current
303,262 GBP2024-12-31
271,323 GBP2023-10-31
Trade Creditors/Trade Payables
Current
295,179 GBP2024-12-31
88,995 GBP2023-10-31
Amounts owed to group undertakings
Current
1,953,935 GBP2024-12-31
253,169 GBP2023-10-31
Taxation/Social Security Payable
Current
186,041 GBP2024-12-31
256,016 GBP2023-10-31
Other Creditors
Current
113,091 GBP2024-12-31
52,368 GBP2023-10-31
Accrued Liabilities/Deferred Income
Current
676,239 GBP2024-12-31
378,026 GBP2023-10-31
Creditors
Current
3,224,485 GBP2024-12-31
1,028,574 GBP2023-10-31
Net Deferred Tax Liability/Asset
7,547 GBP2024-12-31
6,401 GBP2023-10-31
7,701 GBP2022-11-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
1,146 GBP2023-11-01 ~ 2024-12-31
-1,300 GBP2022-11-01 ~ 2023-10-31
Deferred Tax Liabilities
Accelerated tax depreciation
7,547 GBP2024-12-31
9,773 GBP2023-10-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,000 shares2024-12-31
1,000 shares2023-10-31
Par Value of Share
Class 1 ordinary share
1.002023-11-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
1 shares2024-12-31
1 shares2023-10-31
Par Value of Share
Class 2 ordinary share
1.002023-11-01 ~ 2024-12-31
  • MAP PATIENT ACCESS LIMITED
    Info
    MAP BIOPHARMA LIMITED - 2022-01-25
    MAP PHARMA LTD - 2022-01-25
    Registered number 08209281
    Upper Pendrill Court Ermine Street North, Papworth Everard, Cambridge, Cambridgeshire CB23 3UY
    PRIVATE LIMITED COMPANY incorporated on 2012-09-11 (13 years 8 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-09-10
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.